Comprehensive Plant-Based Vaccines Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Plant-Based Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of plant-based vaccines has experienced robust growth in the recent past. A surge from $1.66 billion in 2024 to $1.81 billion in 2025, translating to a compound annual growth rate (CAGR) of 8.9%, is expected. The historical increase can be traced back to issues with conventional vaccine production, the demand for more affordable vaccine manufacturing, the advent of plant molecular farming, the diminished likelihood of causing allergic reactions, and the application of synthetic biology.

Plant-Based Vaccines Market Size Forecast: What's the Projected Valuation by 2029?
Growth is anticipated to surge swiftly in the forthcoming years in the market for plant-based vaccines, with projections estimating a climb to "$2.72 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.8%. This expansion during the forecasted period can be linked to readiness for pandemics, worldwide health security, the broadening of vaccine uses, and acceptance in the pharmaceutical industry. The expected phase is marked by significant trends such as advancements in plant biotechnology, attention to environmental sustainability, incorporation of artificial intelligence, and the inclusion of machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

What Are the Drivers Transforming the Plant-Based Vaccines Market?
The plant-based vaccine market's growth is poised to accelerate due to the high incidence of infectious diseases. These diseases typically arise from various microorganisms such as bacteria, viruses, fungi, and parasites. Plant-based vaccines function as safe, effective, stable, and affordable preventative measures and treatments for diverse illnesses, notably infectious diseases. For instance, the Global Tuberculosis Report released by the World Health Organization, a health agency based in Switzerland, in October 2022, disclosed that the incidence of tuberculosis (TB) globally was approximated at 10.6 million cases, equivalent to 134 cases per 100,000 individuals. The Southeast Asia region reported most of these TB cases, constituting 45% of the global total, followed by Africa, accounting for 23% of the cases. Consequently, the escalating prevalence of infectious diseases is instigating the expansion of the plant-based vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Plant-Based Vaccines Market?
One significant trend sweeping the plant-based vaccine market is product innovation. The sector's leading enterprises, such as Medicago Inc. and GSK PLC, are intensifying efforts to create novel products to maintain their market standing. In February 2022, these two companies - a biopharmaceutical firm from Canada and a British pharmaceutical and biotechnology company respectively - broadcasted that COVIFENZ, a COVID-19 vaccine, had received approval from Health Canada. This vaccine, which uses COVID-19-like particle (CoVLP) technology, is the first plant-based vaccine of its kind to use recombinant, adjuvanted virus-like particles (VLPs). These VLPs comprise recombinant spike (S) glycoproteins, making COVIFENZ a groundbreaking development in the fight against the COVID-19 disease.

Which Segments in the Plant-Based Vaccines Market Offer the Most Profit Potential?
The plant-based vaccines market covered in this report is segmented -

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) By Source: Tobacco Plant, Maize, Potato, Other Sources
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

Which Firms Dominate the Plant-Based Vaccines Market by Market Share and Revenue in 2025?
Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

Which Regions Offer the Highest Growth Potential in the Plant-Based Vaccines Market?
North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12144

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.